by SWK Holdings | Jul 6, 2022 | 2022, archive
Guest Column originally published in Outsourced Pharma, June 29, 2022 The Federal Reserve’s move to raise interest rates to battle inflation – now running at approximately 8% annually – has altered the risk and return for investors who are dealing with rising...
by SWK Holdings | Jun 30, 2022 | 2022, archive
The primary motivation for growth stage companies to explore venture debt as a source of funding is to avoid the dilution that results from a round of equity financing. While venture debt will certainly be much less dilutive than an equity raise, prospective borrowers...
